Which is more trustworthy, the Geneva-based World Health Organization (WHO) or our very own Food and Drug Administration (FDA)?
Well, it’s time to decide.
This, after the World Health Organization (WHO) had strongly recommended that booster shots be given to persons over 60 who had been previously jabbed with the China-made vaccines Sinovac or Sinopharm.
The WHO panel stressed senior citizens should be given boosters “some one to three months” after completing their two doses as the efficacy of Sinovac and Sinopharm vaccines was seen to wane over time.
This conclusion was, however, quickly contradicted by the FDA which said that booster shots for the older population shouldn’t be rolled out just right now because there is no proof that the efficacy of the current lot has diminished.
“It is going on six months and we still haven’t seen a huge spike in Covid infections,” according to FDA director Eric Domingo.
But this did not jibe with the observation of Joachim Hombach of the Strategic Advisory Group of Experts (SAGE) that in older groups, Sinovac and Sinopharm vaccines “performed less well after two doses.”
The WHO stressed that immunocompromised persons be given an additional dose of Covid19 vaccine due to their higher risk of breakthrough infections after standard immunization.
Sinovac, Sinopharm, Pfizer, Moderna, AstraZenaca and Janssen vaccines were previously given emergency use approval for the pandemic by the WHO.